Status:
RECRUITING
High Resolution Imaging for Analysis of MVNT
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Benign Neuronal Desease
Eligibility:
All Genders
18+ years
Brief Summary
MVNT (multinodular and vacuolating neuronal tumor of the cerebrum) is a benign, recently discovered, neuronal lesion, the incidence of which is unknown. It seems to predominate in the temporal lobes ...
Eligibility Criteria
Inclusion
- Patient over 18 years of age
- Prospective inclusion of all patients with suspected MVNT on a first exploratory MRI: at least the 2 major criteria associated with at least 1 minor criterion will be required to fit into the definition of suspected MVNT:
- Major criteria :
- Multinomodular clustered appearance
- Franc hypersignal FLAIR/T2
- Minor criteria :
- No mass effect
- Hyposignal T1
- Having received informed information about the study and having given express consent to participate in the study
Exclusion
- Contraindication to MRI
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
- Secondary exclusion criteria:
- \- No characterization MRI done
Key Trial Info
Start Date :
March 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 19 2027
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04285125
Start Date
March 5 2020
End Date
May 19 2027
Last Update
January 5 2026
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Pellegrin
Bordeaux, Bordeaux, France, 33076
2
CHU Rennes
Rennes, Rennes, France, 35033
3
CHU de Rouen
Rouen, Rouen, France, 76000
4
Hôpital Pierre Paul Riquet, CHU Purpan
Toulouse, Toulouse, France, 31059